Abstract
Candida albicans expresses a CR3-related protein (CR3-RP) antigenically, structurally and functionally related to human adhesion glycoprotein, also known as Mac-l, the iC3b receptor, or complement receptor type 3. The purpose of the present study was to analyze the immunogenic properties of a novel CR3-RP glycoconjugate in a rabbit model. Cell-mediated responses revealed immunoenhancement triggered by CR3-RP glycoconjugate with respect to expression of IL-2 receptor subunit CD25 on B-lymphocytes and inductive increase of the CD4+/CD8+ ratio compared with unconjugated cell wall mannan (P<0.001). Active immunization with the CR3-RP glycoconjugate resulted in an effective IgM-IgG isotypic switch even after the second booster. Altogether, it could be assumed that the novel peptide glycoconjugate is a prospective antigenic candidate for further Candida vaccine design. © 2008 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Paulovičová, E., Bystrický, S., Machová, E., & Bujdáková, H. (2008). Immune responsiveness of a novel peptidoglycan conjugate prepared from surface Candida immunogens: Mannan and CR3-related protein. FEMS Immunology and Medical Microbiology, 53(3), 421–428. https://doi.org/10.1111/j.1574-695X.2008.00442.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.